Ligand Pharmaceuticals Reports Third Quarter 2026 Financial Results

Ligand Pharmaceuticals reported its third-quarter and first nine months of 2026 financial results on October 29, 2026. Royalty revenue rose 51% year over year, which the company attributed to contributions from the XOMA portfolio. Ligand also issued an updated operating forecast and business outlook and scheduled a conference call and webcast to discuss the results.